Pharmaxis Encouraged by First Results in Bone Marrow Cancer Trial
30th
Jun 21
Release Date: 30/06/2021 3:00pm
Pharmaxis CEO Gary Phillips speaks to Proactive Investors about the myelofibrosis clinical trial which is being conducted with patients in Australia and South Korea and the potential for other cancer indications.
Watch the interview here.
Categories: Video Content